Suvorexant’s adverse effects, including sense of looming doom, failed to keep FDA up at night According to the New Yorker magazine, in May of 2013 a team from the pharmaceutical company Merck “hoped to persuade [an FDA] committee of seventeen, composed largely of neurologists, that suvorexant was safe and effective” as a sleep medication. The committee, […]